Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cell and Tissue-Based Therapy”

176 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 176 results

Not applicableNot Yet RecruitingNCT07449988
What this trial is testing

Modified Platform Trial Assessing Multiple Umbilical Cord-based CAMPs and SOC v SOC Alone in the Treatment of Hard-to-Heal VLUs

Who this might be right for
Venous Leg UlcersVenous Leg Ulcers (VLUs)Venous Leg+2 more
StimLabs 272
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07775313
What this trial is testing

Base-Edited Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of CXCR4-WHIM

Who this might be right for
WHIMWartsHypogammaglobulinemia+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 10
Early research (Phase 1)Looking for participantsNCT05139056
What this trial is testing

Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas

Who this might be right for
Currently Only Enrolling Glioblastoma Patients at First Recurrence
City of Hope Medical Center 36
Early research (Phase 1)Active Not RecruitingNCT04750954
What this trial is testing

Testing the Addition of An Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Pancreatic Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Neoplasm
National Cancer Institute (NCI) 29
Not applicableActive Not RecruitingNCT07022457
What this trial is testing

UK ENcorafenib and BInimetinib Real-world Study in Melanoma

Who this might be right for
Metastatic Melanoma, BRAF V600 Mutation Positive
Pierre Fabre Ltd 50
Testing effectiveness (Phase 2)Study completedNCT00846456
What this trial is testing

Safe Study of Dendritic Cell (DC) Based Therapy Targeting Tumor Stem Cells in Glioblastoma

Who this might be right for
GlioblastomaBrain Tumor
Oslo University Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00448357
What this trial is testing

Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
UNC Lineberger Comprehensive Cancer Center 54
Not applicableStudy completedNCT06713395
What this trial is testing

PERMA-Based Intervention on Negative Emotions, Adherence, and Complications in Postoperative Glioma Patients

Who this might be right for
Glioma
Yang Huang 124
Testing effectiveness (Phase 2)Looking for participantsNCT05269381
What this trial is testing

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more
Mayo Clinic 138
Not applicableStudy completedNCT02975960
What this trial is testing

ADMSCs for the Treatment of Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
The Catholic University of Korea 7
Testing effectiveness (Phase 2)Ended earlyNCT01026051
What this trial is testing

Safety, Immune and Tumor Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma

Who this might be right for
Stage III MelanomaStage IV Melanoma
Mannkind Corporation 5
Testing effectiveness (Phase 2)Ended earlyNCT00197925
What this trial is testing

Dendritic Cell Based Therapy of Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Herlev Hospital 40
Not applicableStudy completedNCT05819255
What this trial is testing

TRAQinform Assessment of Immunotherapy Response

Who this might be right for
Melanoma
AIQ Solutions 26
Not applicableStudy completedNCT00897663
What this trial is testing

Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies

Who this might be right for
Brain and Central Nervous System Tumors
Alliance for Clinical Trials in Oncology 56
Large-scale testing (Phase 3)Study completedNCT00382018
What this trial is testing

S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With Chemo

Who this might be right for
Breast Cancer
SWOG Cancer Research Network 624
Early research (Phase 1)Ended earlyNCT03674827
What this trial is testing

Vaccine-Based Immunotherapy Regimen For NSCLC and TNBC

Who this might be right for
Non-Small Cell Lung CancerTriple-negative Breast Cancer
Pfizer 36
Early research (Phase 1)Study completedNCT01588769
What this trial is testing

A Phase I Study to Investigate Tolerability and Efficacy of ALECSAT Administered to Glioblastoma Multiforme Patients

Who this might be right for
Glioblastoma Multiforme
CytoVac A/S 23
Not applicableEnrolling By InvitationNCT07499128
What this trial is testing

Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event

Who this might be right for
Cytokine Release SyndromeNeoplasmsLymphoma+13 more
National Cancer Institute (NCI) 136
Early research (Phase 1)Active Not RecruitingNCT04234568
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Neuroendocrine Tumors

Who this might be right for
Metastatic Digestive System Neuroendocrine NeoplasmMetastatic Neuroendocrine Tumor
National Cancer Institute (NCI) 31
Early research (Phase 1)Study completedNCT02179515
What this trial is testing

Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM)

Who this might be right for
Lung CancerBreast CancerProstate Cancer+2 more
National Cancer Institute (NCI) 38
Next Page